Audrey Ménard

CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study

Pierre Péterlin, Yannick Le Bris, Pascal Turlure et al. · The Lancet Haematology · 2023 · 24 citations

Medicine, Hematology, Oncology +12

CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma

Salomé Decombis, Céline Bellanger, Yannick Le Bris et al. · Blood · 2023 · 23 citations · Full text

Medicine, Cell Biology, Oncology +12

<scp>BCR</scp>‐<scp>ABL</scp>1 molecular remission after ⁹⁰<scp>Y</scp>‐epratuzumab tetraxetan radioimmunotherapy in <scp>CD</scp>22⁺<scp>P</scp>h⁺<scp>B</scp>‐<scp>ALL</scp>: proof of principle

Patrice Chevallier, Caroline Bodet‐Milin, Nelly Robillard et al. · European Journal Of Haematology · 2013 · 19 citations

Medicine, Hematology, Oncology +16

Molecular characterization and follow‐up of five <scp>CML</scp> patients with new <scp>BCR–ABL</scp>1 fusion transcripts

Sarah Huet, Stéphanie Dulucq, Aurélie Chauveau et al. · Genes Chromosomes and Cancer · 2015 · 19 citations

Life Sciences, Hematology, Molecular Biology +16

Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study

Sophie Vantyghem, Pierre Péterlin, Sylvain Thépot et al. · Haematologica · 2020 · 11 citations · Full text

Medicine, Hematology, Oncology +17